Loang, Janice .

HRN: 20-67-21  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/01/2025
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
03/01/2025
03/08/2025
IV
4.5g
Q8h
T/c SLE In Flare
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: